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Year Number of Cases Number of 
Fatalities
2000 0 0
2001 3 1
2002 22 3
2003 17 1
2004 0 0
2005 6 1
2006 3 0
2007 6 0
2008 0 1
2009 0 0
2010 7 0
2011 6 0
2012 33 1
Total 103 8
Human WNV Cases Confirmed in Massachusetts 
Residents by Year, 2000-2012
                            
Background 
West Nile virus (WNV) is a flavivirus first isolated in 
1937 from a resident of the West Nile district of 
Uganda.  It was introduced into the United States in 
1999 and is now found in most parts of the country, 
ncluding Massachusetts.   i
 
The virus is maintained in nature in a bird-mosquito 
cycle that occasionally spills over into mammals, 
including humans.  Humans are considered incidental 
hosts and do not perpetuate the cycle.  The greatest 
risk for human infection with WNV in Massachusetts 
ccurs generally in early August through late October.  o
 
While the majority of human infections with WNV 
have resulted from bites by infected mosquitoes, other 
rare modes of transmission have been identified, 
including blood transfusion and organ transplantation 
from infected donors, occupational sharps injury 
exposures, transplacental transmission, and probable 
transmission via breast milk. 
When to Suspect WNV 
The incubation period for WNV infection ranges from 2 to 14 days.  While most WNV infections are 
asymptomatic, 20% of those infected may experience a systemic, self-limited illness with headache, myalgias 
and arthralgias, which is sometimes accompanied by skin rash or lymphadenopathy.  Approximately 1% of 
those infected experience a more severe illness, with central nervous system (CNS) involvement.  The 
frequency and severity of clinical illness increase as age increases.  When the CNS is affected, clinical 
syndromes include aseptic meningitis, encephalitis and myelitis, which are clinically indistinguishable from 
similar syndromes caused by other viruses. Meningitis is usually characterized by fever, headache, stiff neck, 
and pleocytosis in cerebrospinal fluid. Encephalitis is usually characterized by fever, headache and altered 
mental status ranging from confusion to coma, with or without additional signs of brain dysfunction.  Other 
neurological syndromes include cranial and peripheral neuritis or other neuropathies, including acute flaccid 
paralysis syndrome. Any suspect case of encephalitis or meningitis should be reported as soon as possible 
to the local board of health and the MDPH, Division of Epidemiology and Immunization, at 1-617-983-
6800 or 1-888-658-2850. 
 
Prevention Messages for Your Patients 
• Use an EPA approved mosquito repellent according to the instructions on the product label.  Review the 
MDPH Fact Sheet on Mosquito Repellents online at www.mass.gov/dph/mosquito. Additional information, 
including repellent selector tools, is available at http://cfpub.epa.gov/oppref/insect/ and 
http://pi.ace.orst.edu/repellents/. 
• Wear long pants, a long-sleeved shirt and socks to reduce exposed skin outdoors, weather permitting. 
• Keep mosquitoes out of the house by repairing any holes in screens and making sure they are tightly 
attached to all doors and windows. 
• Remove areas of standing water around the home to reduce mosquito breeding.  
• During the peak risk period, older patients and those that are immune compromised should consider avoiding 
outdoor events between dusk and dawn when mosquitoes most likely to carry WNV are most active. 
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Hinton State Laboratory Institute 
Diagnostic Testing for Arboviruses in Humans 
 
How to Test for WNV 
In order to confirm suspect cases of WNV, it is vital that you send the appropriate samples to the MDPH Hinton 
State Laboratory Institute (HSLI) for testing.  
 
Serologic tests and viral culture are available for diagnostic testing for evidence of infection with West 
Nile virus (WNV), eastern equine encephalitis (EEE) virus and other arboviruses.  PCR is also available 
for detection of RNA of WNV and EEE virus.  Multiple tests will be performed to identify viral infection 
and/or confirm exposure to virus.  Testing may require that follow up (convalescent) specimens be 
submitted.  
  
The following information is critical for accurate interpretation of test results: 
• Date of onset of disease symptoms 
• Date of specimen collection 
• Unusual immunological status of patient (e.g. immunosuppression) 
• Travel history (e.g., travel to flavivirus-endemic areas) 
• Vaccination history (e.g., vaccination against yellow fever, Japanese encephalitis or Central European 
encephalitis) 
• Disease history (e.g., previous history of viral encephalitis or dengue fever) 
• Brief clinical summary including suspected diagnosis (e.g., encephalitis or meningitis) 
 
Specimen types and amounts 
Acute serum (≥ 3ml) and CSF (≥ 1ml) should be collected within the first 14 days following onset of symptoms 
and sent immediately to the HSLI.  IgM antibody in serum is present in the majority of infected individuals by 
day 8, but may be present earlier.  By 3 weeks after onset (often earlier), virtually all infected individuals will 
have IgG antibody by enzyme immunoassay (EIA) and plaque reduction neutralization assay (PRNT).  In 
general, convalescent specimens should be drawn approximately 10-14 days after acute phase specimens. 
 
CSF, brain and other tissues will be evaluated by cell culture and, if a sufficient specimen is available, by 
PCR.  Specimens submitted for viral isolation within 48 hrs should be stored and shipped at 4°C.  If 
already frozen, specimens should be shipped on dry ice. 
 
Clinical specimens should be submitted using the State Laboratory Institute’s clinical specimen submission form (SS-
SL-1-05) (http://www.mass.gov/eohhs/docs/dph/laboratory-sciences/general-submission-form.pdf).  Additional 
arboviral information can be found on MDPH’s arbovirus website (http://www.mass.gov/dph/mosquito). 
 
Hinton State Laboratory Institute 
Bureau of Laboratory Sciences 
Division of Molecular Diagnostics and Virology 
305 South Street 
Boston, MA 02130 
Virology Laboratories: (617) 983-6396 or 6382 
 
MDPH Arbovirus Website 
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